Skip Over Navigation Links


BrIDGs Projects

BrIDGs projects benefit from certain critical resources needed for the development of new therapeutic agents. Successful applicants receive access to NIH contractors who conduct pre-clinical synthesis, formulation, pharmacokinetic and toxicology services at no cost to the investigator. Click on the links below to view active and completed BrIDGs projects:

Active Projects


Tony Jackson

BrIDGs News

On Dec. 17, 2013, NIH announced three new projects aimed at advancing treatments for acute radiation syndrome, brain injury from cardiac arrest, and a rare disease called beta thalassemia. Read the NIH news release.